Common use of Centre of Main Interests and Establishments Clause in Contracts

Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UK’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 of 20 May 2015 on insolvency proceedings (recast) on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl Replimune UK’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 on Insolvency Proceedings (recast) (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UK’s its centre of main interest (as that term is used in Article 3(1) of the Regulation) is not situated in England and Wales the US or the United Kingdom and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 on Insolvency Proceedings (recast) (the “"Regulation”"), each of Mesoblast UK’s and Mesoblast Intl UK’s its centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated not in England and Wales the US or the United Kingdom and it has no “"establishment” " (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdictionthe US or the United Kingdom.

Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 on Insolvency Proceedings (recast) (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UK’s its centre of main interest (as that term is used in Article 3(1) of the Regulation) is not situated in England and Wales the United Kingdom or the US and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council Regulation (EU) No 2015/848 of the European Union Regulation No. 1346/2000 20 May 2015 on Insolvency Proceedings insolvency proceedings (recast) (the “Regulation”), each as it forms part of English law by virtue of the European Union Withdrawal (Agreement) Xxx 0000, (the “UK Regulation”), Mesoblast UK’s and Mesoblast Intl UK’s centre of main interest (as that term is used in Article 3(1) of the UK Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 of 20 May 2015 on insolvency proceedings ny-2659060 (recast) on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl Replimune UK’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council Regulation (EU) 2015/848 of the European Union Regulation No. 1346/2000 20 May 2015 on Insolvency Proceedings insolvency proceedings (recast) (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UKUK Incorporated Obligor’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England its jurisdiction of incorporation and Wales and it has no none of them have an “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For for the purposes of The Council of the European Union Regulation No. 1346/2000 on Insolvency Proceedings and/or Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (recast) (as applicable) (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UK’s ) its centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales the United Kingdom and it has no “establishment” (as that term is used in Article 2(h) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council of the European Union Regulation No. 1346/2000 2015/848 of 20 May 2015 on insolvency proceedings (recast) on Insolvency Proceedings (the “Regulation”), each of Mesoblast UK’s the Company’s, COMPASS Pathfinder Holdings’ and Mesoblast Intl UKCOMPASS Pathfinder Limited’s centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council Regulation (EU) 2015/848 of the European Union Regulation No. 1346/2000 20 May 2015 on Insolvency Proceedings insolvency proceedings (recast) (the “"Regulation”"), each of Mesoblast UK’s and Mesoblast Intl UK’s UK Incorporated Obligor's centre of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England its jurisdiction of incorporation and Wales and it has no “none of them have an "establishment” " (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council regulation (EU) 2015/848 of the European Union Regulation No. 1346/2000 20 May 2015 on Insolvency Proceedings insolvency proceedings (recast) (the “Regulation”), each of Mesoblast UK’s and Mesoblast Intl UK’s the UK Subsidiaries’ centre of main interest (as that term is used in Article 3(13(l) of the Regulation) is situated in England its jurisdiction of incorporation and Wales and it has no none of them have an “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.

Centre of Main Interests and Establishments. For the purposes of The Council Regulation (EU) 2015/848 of the European Union Regulation 20 May 2015 on insolvency proceedings (recast) No. 1346/2000 on Insolvency Proceedings (the “Regulation”), each of Mesoblast Apollo UK’s and Mesoblast Intl UK’s centre center of main interest (as that term is used in Article 3(1) of the Regulation) is situated in England and Wales and it has no “establishment” (as that term is used in Article 2(h2(10) of the Regulation) in any other jurisdiction.